Authors:
GALLEN M
ALONSO C
OJEDA B
VILADIU P
BELTRAN M
BORRAS J
PELEGRI A
TUSQUETS I
BARNADAS A
ARCUSA A
BASTUS R
BALIL A
BATISTEALENTORN E
BOLEDA M
BADIA MA
GARAU I
GUASH I
Citation: M. Gallen et al., RANDOMIZED TRIAL OF 2 VERSUS 4 YEARS OF ADJUVANT TAMOXIFEN (AT) FOR POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER, European journal of cancer, 34, 1998, pp. 101-101
Authors:
PELEGRI A
BARNADAS A
ESCOBEDO A
RIFA J
MARTIN J
LAINEZ N
GIL M
BELLET M
ROSELL R
BORRAS J
Citation: A. Pelegri et al., ADJUVANT DOX -] CMF IN PATIENTS WITH BREAST-CANCER (BC) AND 4 OR MOREPOSITIVE NODES (GREATER-THAN-OR-EQUAL-TO-4- CAN MILAN TRIAL RESULTS BE REPRODUCED IN CLINICAL SETTING(LN) ), Annals of oncology, 9, 1998, pp. 27-27
Authors:
PEDROBOTET J
SENTI M
RUBIESPRAT J
PELEGRI A
ROMERO R
Citation: J. Pedrobotet et al., WHEN TO TREAT DYSLIPIDEMIA OF PATIENTS WITH CHRONIC-RENAL-FAILURE ON HEMODIALYSIS - A NEED TO DEFINE SPECIFIC GUIDELINES, Nephrology, dialysis, transplantation, 11(2), 1996, pp. 308-313
Authors:
AUGUET T
SENTI M
RUBIESPRAT J
PELEGRI A
PEDROBOTET J
NOGUES X
ROMERO R
Citation: T. Auguet et al., SERUM LIPOPROTEIN(A) CONCENTRATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE RECEIVING HEMODIALYSIS - INFLUENCE OF APOLIPOPROTEIN(A) GENETIC-POLYMORPHISM, Nephrology, dialysis, transplantation, 8(10), 1993, pp. 1099-1103
Authors:
RODRIGUEZ JA
ROCA R
PELEGRI A
BUTI M
JARDI R
BARTOLOME J
FORT J
CAMPS J
ESTEBAN R
OLMOS A
PIERA L
Citation: Ja. Rodriguez et al., HIGHER PREVALENCE OF ANTIBODIES AGAINST HEPATITIS-C VIRUS (HCV) IN PATIENTS ON HEMODIALYSIS (HD), Kidney international, 44(6), 1993, pp. 1402-1402
Authors:
RODRIGUEZ JA
CARAGOL I
ROCA R
PELEGRI A
ESPANOL T
FORT J
OLMOS A
PIERA L
Citation: Ja. Rodriguez et al., STUDY OF LYMPHOCYTE POPULATIONS (LP) IN HEMODIALYSIS-PATIENTS (HP) TREATED WITH RECOMBINANT ERYTHROPOIETIN (RHUEPO), Kidney international, 44(6), 1993, pp. 1430-1430
Authors:
RODRIGUEZ JA
ROCA R
PELEGRI A
BUTI M
JARDI R
BARTOLOME J
FORT J
CAMPS J
ESTEBAN R
OLMOS A
PIERA L
Citation: Ja. Rodriguez et al., INCREASED IMMUNIZATION AFTER HEPATITIS-B VACCINATION IN PATIENTS UNDER TREATMENT WITH RHUEPO, Kidney international, 44(6), 1993, pp. 1430-1430
Authors:
PELEGRI A
ROCA R
RODRIGUEZ JA
FORT J
MAYOL A
CAMPS J
Citation: A. Pelegri et al., VALUATION UPON THE ROUTE OF ADMINISTRATION OF RHUEPO IN HEMODIALYSIS-PATIENTS (HP), Kidney international, 44(6), 1993, pp. 1430-1430